Can you provide the average price target for MACERICH CO/THE stock?
20 analysts have analysed MAC and the average price target is 21.64 USD. This implies a price increase of 18.05% is expected in the next year compared to the current price of 18.33.
NYSE:MAC • US5543821012
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MACERICH CO/THE (MAC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-10 | JP Morgan | Maintains | Underweight -> Underweight |
| 2026-03-02 | Goldman Sachs | Maintains | Sell -> Sell |
| 2026-02-25 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-23 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2026-02-23 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-01-20 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-19 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-13 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-09-26 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-09-15 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-08-28 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-08-27 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-07-18 | Ladenburg Thalmann | Initiate | Buy |
| 2025-06-10 | Mizuho | Upgrade | Neutral -> Outperform |
| 2025-06-09 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-23 | Piper Sandler | Upgrade | Underweight -> Neutral |
| 2025-04-23 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-04-10 | Truist Securities | Upgrade | Hold -> Buy |
| 2025-04-01 | Truist Securities | Maintains | Hold -> Hold |
| 2025-04-01 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-10 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-03-10 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-03-06 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-02-28 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2025-01-15 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 884.068M 2.89% | 918.204M 3.86% | 1.014B 10.43% | 983.37M -3.02% | 1.026B 4.34% | 1.001B -2.44% | 1.041B 4.00% | 1.1B 5.67% | 1.099B -0.09% | 1.151B 4.73% | 1.207B 4.87% | |
| EBITDA YoY % growth | 473.973M 4.75% | 470.887M -0.65% | 535.864M 13.80% | 633.58M 18.24% | 659.83M 4.14% | 700.72M 6.20% | 586.74M -16.27% | 638.82M 8.88% | 668.57M 4.66% | 699.12M 4.57% | 731.92M 4.69% | |
| EBIT YoY % growth | 177.579M 18.39% | 165.012M -7.08% | 167.761M 1.67% | 227.97M 35.89% | 264.38M 15.97% | 282.24M 6.76% | 225.92M -19.95% | 246.53M 9.12% | 262.69M 6.55% | 279.48M 6.39% | 298.34M 6.75% | |
| Operating Margin | 20.09% | 17.97% | 16.54% | 23.18% | 25.77% | 28.20% | 21.70% | 22.41% | 23.90% | 24.28% | 24.72% | |
| EPS YoY % growth | -1.31 -336.67% | -0.82 37.40% | -0.77 6.10% | -0.13 82.95% | -0.03 73.85% | 0.11 423.53% | 0.10 -9.09% | 0.10 | 0.38 280.00% | 0.47 23.68% | 0.57 19.15% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 50.22% | -0.06 60.32% | -0.03 91.09% | 0.05 176.95% | -0.07 25.61% | -0.04 36.37% | -0.01 55.57% | 0.09 75.00% |
| Revenue Q2Q % growth | 238.24M -4.41% | 241.31M -3.40% | 250.65M -1.03% | 271.13M 3.60% | 234.93M -1.39% | 235.9M -2.24% | 245.46M -2.07% | 279.03M 2.91% |
| EBITDA Q2Q % growth | 144.85M 13.96% | 152.55M -32.97% | 158.54M -51.26% | 177.64M -57.50% | 130.25M -10.08% | 129.37M -15.20% | 137.34M -13.37% | 159.4M -10.27% |
| EBIT Q2Q % growth | 33.857M 6.18% | 42.089M 2.28% | 49.225M 9.71% | 67.123M 34.64% | 19.19M -43.32% | 29.492M -29.93% | 32.017M -34.96% | 55.651M -17.09% |
All data in USD
20 analysts have analysed MAC and the average price target is 21.64 USD. This implies a price increase of 18.05% is expected in the next year compared to the current price of 18.33.
MACERICH CO/THE (MAC) will report earnings on 2026-05-11.
The consensus EPS estimate for the next earnings of MACERICH CO/THE (MAC) is -0.1 USD and the consensus revenue estimate is 238.24M USD.
The expected long term growth rate for MACERICH CO/THE (MAC) is 0.24%.